marbofloxacin has been researched along with Cat Diseases in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hnot, M; Milliron, SM; Myers, AN; Rodrigues Hoffmann, A; Seyler, ZG; Wiener, DJ | 1 |
| Baumann, J; Boretti, FS; Hofmann-Lehmann, R; Naegeli, H; Novacco, M; Oestmann, A; Riond, B; Spiri, AM; Sugiarto, S; Willi, B | 1 |
| Giacometti, F; Magarotto, J; Merialdi, G; Pietra, M; Piva, S; Serraino, A | 1 |
| Anug, Y; Baneth, G; Rojas, A; Yafe, Y; Yasur-Landau, D; Zehavi, T | 1 |
| Boulouis, HJ; El Garch, F; Galland, D; Kroemer, S; Petit, JL; Woehrle, F | 1 |
| Boucraut-Baralon, C; Etievant, M; Jechoux, A; Lanore, D; Pingret, JL; Raymond-Letron, I; Rivière, D | 1 |
| Barker, EN; Cerón, JJ; Eckersall, PD; Knowles, TG; Korman, RM; Tasker, S | 1 |
| Acar, JF; Kroemer, S; Martel, JL; Meunier, D; Valle, M | 1 |
| Bender, JB; Gilbert, SM; LeDell, KH; Olsen, KE; Torres, SM | 1 |
| Caney, SM; Day, MJ; Dean, RS; Gruffydd-Jones, TJ; Helps, CR; Knowles, TG; Lait, PJ; Pinches, MD; Tasker, S | 2 |
| Cavana, P; Farca, AM; Nebbia, P; Robino, P | 1 |
| Boisramé, B; Deleforge, J; Drugeon, H; Spreng, M; Thomas, V | 1 |
| Dossin, O; Gruet, P; Thomas, E | 1 |
| Carbone, M; De Sarro, A; Fera, MT; Giannone, M; Masucci, M; Pennisi, MG | 1 |
3 trial(s) available for marbofloxacin and Cat Diseases
| Article | Year |
|---|---|
Acute phase response to Mycoplasma haemofelis and 'Candidatus Mycoplasma haemominutum' infection in FIV-infected and non-FIV-infected cats.
Topics: Acute-Phase Proteins; Acute-Phase Reaction; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Chronic Disease; Coinfection; Drug Administration Schedule; Fluoroquinolones; Haptoglobins; Immunodeficiency Virus, Feline; Lentivirus Infections; Mycoplasma; Mycoplasma Infections; Nephelometry and Turbidimetry; Orosomucoid; Serum Amyloid A Protein; Species Specificity; Specific Pathogen-Free Organisms | 2012 |
Effect of chronic feline immunodeficiency infection, and efficacy of marbofloxacin treatment, on 'Candidatus Mycoplasma haemominutum' infection.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; DNA, Bacterial; Drug Administration Schedule; Female; Fluoroquinolones; Lentivirus Infections; Male; Mycoplasma; Mycoplasma Infections; Quinolones; Specific Pathogen-Free Organisms | 2006 |
Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolates.
Topics: Animals; Anti-Infective Agents; Bordetella bronchiseptica; Bordetella Infections; Cat Diseases; Cats; Ciprofloxacin; Enrofloxacin; Female; Fluoroquinolones; Male; Microbial Sensitivity Tests; Quinolones | 2001 |
12 other study(ies) available for marbofloxacin and Cat Diseases
| Article | Year |
|---|---|
Pyogranulomatous panniculitis in a domestic cat associated with Pseudomonas luteola infection.
Topics: Animals; Cat Diseases; Cats; Fluoroquinolones; Panniculitis; Pseudomonas; Pseudomonas Infections; Treatment Outcome | 2021 |
Consecutive antibiotic treatment with doxycycline and marbofloxacin clears bacteremia in Mycoplasma haemofelis-infected cats.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bacteremia; Bacterial Load; Cat Diseases; Cats; DNA, Bacterial; Doxycycline; Fluoroquinolones; Immunosuppression Therapy; Methylprednisolone; Mycoplasma; Mycoplasma Infections; Real-Time Polymerase Chain Reaction; Treatment Outcome | 2018 |
First description of Streptococcus lutetiensis from a diseased cat.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clindamycin; Diarrhea; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Female; Fluoroquinolones; Intestinal Neoplasms; Intestines; Lymphoma; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptococcal Infections; Streptococcus; Tetracycline | 2019 |
First molecular identification of Aelurostrongylus abstrusus in a cat presenting severe respiratory disease from Israel.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Antinematodal Agents; Bayes Theorem; Bronchoalveolar Lavage Fluid; Cat Diseases; Cats; DNA, Helminth; Feces; Fenbendazole; Fluoroquinolones; Israel; Larva; Lung; Male; Metastrongyloidea; Phylogeny; Polymerase Chain Reaction; Prednisolone; Radiography, Thoracic; Strongylida Infections | 2019 |
Antibiotic susceptibility of bacteria isolated from infections in cats and dogs throughout Europe (2002-2009).
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Europe; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Otitis; Respiratory Tract Infections; Skin Diseases, Bacterial; Treatment Outcome; Urinary Tract Infections | 2014 |
Disseminated Mycobacterium avium subspecies infection in a cat.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Cefoxitin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fatal Outcome; Fluoroquinolones; Male; Mycobacterium avium; Rifampin; Tuberculosis | 2011 |
A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets.
Topics: Animals; Animals, Domestic; Cat Diseases; Cats; Data Collection; Dog Diseases; Dogs; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Quinolones | 2004 |
Isolation of methicillin-resistant Staphylococcus aureus from a non-healing abscess in a cat.
Topics: Abscess; Animals; Cat Diseases; Cats; Diagnosis, Differential; Enzyme Inhibitors; Fluoroquinolones; Foot; Forelimb; Male; Methicillin Resistance; Quinolones; Staphylococcal Skin Infections; Staphylococcus aureus; Topoisomerase II Inhibitors | 2005 |
Effect of chronic FIV infection, and efficacy of marbofloxacin treatment, on Mycoplasma haemofelis infection.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Chronic Disease; Colony Count, Microbial; Feline Acquired Immunodeficiency Syndrome; Female; Fluoroquinolones; Male; Mycoplasma; Mycoplasma Infections; Polymerase Chain Reaction; Quinolones; Random Allocation; Time Factors; Treatment Outcome; Viral Load | 2006 |
In vitro antimicrobial activity of marbofloxacin and enrofloxacin against bacterial strains isolated from companion animals.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Colony Count, Microbial; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Quinolones; Treatment Outcome | 2007 |
Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacteriuria; Cat Diseases; Cats; Dog Diseases; Dogs; Enzyme Inhibitors; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Pasteurella multocida; Quinolones; Staphylococcus; Staphylococcus aureus; Topoisomerase II Inhibitors | 1995 |
Comparative field evaluation of marbofloxacin tablets in the treatment of feline upper respiratory infections.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Infective Agents; Cat Diseases; Cats; Fluoroquinolones; Quinolones; Random Allocation; Respiratory Tract Infections; Treatment Outcome | 1998 |